Genesis MedTech & NUHS Partner to Advance AI-Driven Surgical Innovation

The partnership will establish the Genesis-NUHS AI Innovation and Surgical Training Lab, creating a dedicated hub for developing and testing AI-powered surgical tools with clinicians embedded throughout the design process.

Genesis MedTech Group and the National University Health System (NUHS) in Singapore have entered a strategic partnership to accelerate the use of artificial intelligence in surgery and medical device innovation.

The collaboration, formalized earlier this year through a Memorandum of Understanding and detailed at the World Congress of Endoscopic Surgery, has been structured as a two-phase programme aimed at advancing AI-enabled surgical solutions.

The Genesis MedTech-NUHS AI Innovation Partnership has been structured as a two-phase, four-year programme that uses a design-led approach to translate unmet surgical needs into clinically meaningful AI solutions.

The initiative will focus on co-innovating AI projects in surgery, engaging NUHS clinicians throughout the development process, and building infrastructure to support experimentation, training, and deployment.

As part of the collaboration, the partners will establish the “Genesis-NUHS AI Innovation and Surgical Training Lab,” which will act as a hub for developing and testing AI-powered surgical tools, training clinicians, and refining workflow integration. The lab is intended to support the transition from concept to real-world clinical adoption, with an emphasis on safety, usability, and measurable improvements in surgical outcomes.

“Innovation in healthcare happens where clinicians and engineers meet,” said Warren Wang, chairman and chief executive officer of Genesis MedTech. “Our partnership with NUHS represents our commitment to advancing AI-powered surgical innovation - built around real clinical challenges, developed hand-in-hand with hospitals.”

Adjunct Professor Ngiam Kee Yuan, head of the AI Office at NUHS, highlighted the potential of the collaboration to speed up AI adoption in surgical care.

“By combining NUHS's clinical and academic excellence with Genesis MedTech's global innovation platform, we aim to accelerate AI adoption to improve surgical care for patients in Singapore and internationally,” he said.

The partners said AI-driven technologies are increasingly being used to give surgeons data-driven insights before, during, and after procedures, helping deliver safer, more personalized outcomes while supporting hospitals in delivering cost-effective care.

Stay tuned for more such updates on Digital Health News